User:Ajeffs: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
Line 45: Line 45:
==Funding==
==Funding==
===2011===
===2011===
*"p53 isoforms, miRNA, cancer", Dunedin School of Medicine Dean's Bequest Round, 27 May 2011 for 1 year ($14,569). A. Jeffs and A. Braithwaite.
*"p53 isoforms, miRNA, and cancer", Dunedin School of Medicine Dean's Bequest Round, 27 May 2011 for 1 year ($14,569). A. Jeffs and A. Braithwaite.


===2010===
===2010===

Revision as of 01:37, 1 July 2011

Aaron Jeffs

Department of Pathology
Dunedin School of Medicine
University of Otago
Dunedin
New Zealand

aaron.jeffs at otago.ac.nz

Research Interests

  • Cancer genetics
  • Oncogenomics
  • eResearch

Education

  • PhD (Otago) 2001.
  • MSc Hons (Canterbury) 1994.

Funding

2011

  • "p53 isoforms, miRNA, and cancer", Dunedin School of Medicine Dean's Bequest Round, 27 May 2011 for 1 year ($14,569). A. Jeffs and A. Braithwaite.

2010

  • "MicroRNA function in melanoma", The Healthcare Otago Charitable Trust, October 2010 for 1 year ($14,127). A. Jeffs.
  • "Urinary microRNA: a novel marker of acute kidney injury", University of Otago Research grant, October 2010 for 1 year ($44,000). R. Walker (PI), A. Jeffs, Z. Endre, and J. Pickering.
  • "Can isoforms of the p53 tumour suppressor cause cancer?", Health Research Council of New Zealand, June 2010 for 36 months ($1,158,492). A. Braithwaite (PI), N. Hung, A. Jeffs, and T. Slatter.
  • "A novel gene that modifies melanoma invasive potential", Dunedin School of Medicine Dean's Bequest Fund, June 2010 for 1 year ($5420). A. Jeffs.
  • "Grant-in-aid for QMB Cancer meeting 2010", Maurice & Phyllis Paykel Trust ($4000). A. Jeffs & M. Eccles.
  • Professional Development Award to attend the AMATA10 meeting, Hobart, Australia, Genesis Oncology Trust ($1,957). A. Jeffs.
  • Dunedin School of Medicine Travel Grant to attend the AMATA10 meeting, Hobart, Australia ($885). A.Jeffs.

2009

  • "Genome instability in melanoma", NZ Lottery Grants Board (Application 278243), 01/01/2010 for 2 years ($116,328). A. Jeffs (PI), M. Eccles, and B. Baguley.
  • "The molecular basis of melanoma: integrating microRNA expression and DNA copy number variation to define clinically relevant markers of invasion and prognosis", The HealthCare Otago Charitable Trust ($10,434), 01/02/10 for 1 year. A. Jeffs.